參考文獻(xiàn)/References:
[1] Mizukami A, Swiech K.Mesenchymal stromal cells: from discovery to manufacturing and commercialization[J].Stem Cells Int,2018:4083921.
[2] Borges F T, Convento M B, Schor N.Bone marrow-derived mesenchymal stromal cell: what next-[J].Stem Cells Cloning,2018(11):77-83.
[3] Oikonomopoulos A, van Deen W K, Manansala A R, et al.Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media[J]. Sci Rep,2015(5):16570.
[4] Liu S,Zhou J, Zhang X, et al.Strategies to optimize adult stem cell therapy for tissue regeneration[J]. Int J Mol Sci,2016, 17(6):E982.
[5] Mishra PJ, Banerjee D.Activation and Differentiation of Mesenchymal Stem Cells[J].Methods Mol Biol,2017,1554:201-209.
[6] Mendicino M,Bailey A M,Wonnacott K,et al.MSC-based product characterization for clinical trials: An FDA perspective[J]. Cell Stem Cell,2014,14(2):141-145.
[7] Bandeiras C, Cabral J M, Finkelstein S N, et al.Modeling biological and economic uncertainty on cell therapy manufacturing: the choice of culture media supplementation[J]. Regen Med,2018,13(8):917.
[8] Ullah I, Subbarao R G, Rho G J.Human mesenchymal stem cells-current trends and future prospective[J]. Biosci Rep, 2015,35(2):e00191.
[9] Ikebe C,Suzuki K.Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols[J]. Biomed Res Int,2014:951512.
[10] Spees J L, Gregory C A, Singh H, et al.Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy[J]. Mol Ther,2004,9(5):747-756.
[11] Dahl J A, Duggal S, Coulston N, et al.Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum[J]. Int J Dev Biol,2008, 52(8):1033-1042.
[12] Fitzsimmons R E B,Mazurek M S,Soos A, et al.Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering[J]. Stem Cells Int,2018:8031718.
[13] Amable P R,Carias R B,Teixeira M V,et al.Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors[J].Stem Cell Res Ther,2013,4(3):67.
[14] Burnouf T, Strunk D, Koh M B, et al.Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation- [J]. Biomaterials,2016,76:371.
[15] Fekete N, Gadelorge M, Fürst D,et al.Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components[J]. Cytotherapy,2012,14(5):540-554.
[16] Shih D T, Burnouf T.Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion[J]. N Biotechnol, 2015,32(1):199-211.
[17] Mojica-Henshaw M P, Jacobson P, Morris J,et al.Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures[J].Cytotherapy,2013,15(12):1458-1468.
[18] Horn P,Bokermann G,Cholewa D, et al.Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells[J].Cytotherapy,2010,12(7):888-898.
[19] Pierce J,Benedetti E, Preslar A,et al.Comparative analyses of industrial-scale human platelet lysate preparations[J].Transfusion,2017,57(12):2858-2869.
[20] Lohmann M, Walenda G, Hemeda H, et al.Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells[J]. PLoS One, 2012,7(5):e37839.
[21] Astori G, Amati E, Bambi F, et al.Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future[J]. Stem Cell Res Ther,2016,7(1):93.
[22] Fernandez-Rebollo E, Mentrup B, Ebert R,et al.Human platelet lysate versus fetal calf serum: these supplements do not select for different mesenchymal stromal cells[J]. Sci Rep,2017,7(1):5132.
[23] Schallmoser K, Strunk D.Generation of a pool of human platelet lysate and efficient use in cell culture[J]. Methods Mol Biol,2013,946:349-362.
[24] McGrath M, Tam E, Sladkova M, et al.GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells[J]. Stem Cell Res Ther,2019,10(1):11.
[25] Chase L G, Lakshmipathy U, Solchaga L A, et al.A novel serum-free medium for the expansion of human mesenchymal stem cells[J]. Stem Cell Res Ther,2010,1(1):8.
[26] Devireddy L R, Myers M, Screven R, et al.A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem/stromal cells[J]. PLoS One,2019,14(2):e0210250.
[27] Liu Z, Screven R, Boxer L, et al.Characterization of Canine Adipose-Derived Mesenchymal Stromal/Stem Cells in Serum-Free Medium[J]. Tissue Eng Part C Methods,2018,24(7):399.
[28] Schubert S, Brehm W, Hillmann A, et al.Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture[J]. Cytometry A,2018,93(1):60-72.
[29] Lee M S,Youn C,Kim J H, et al.Enhanced cell growth of adipocyte-derived mesenchymal stem cells using chemically-defined serum-free media[J]. Int J Mol Sci,2017,18(8):E 1779.
[30] Ben Azouna N, Jenhani F, Regaya Z, et al.Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum [J]. Stem Cell Res Ther,2012,3(1):6.